Literature DB >> 18066482

Efficacy of tolterodine in relation to different urodynamic findings of detrusor overactivity.

Stefano Salvatore1, Maurizio Serati, G Alessandro Digesu, Paola Triacca, Stefano Uccella, Vik Khullar, PierFrancesco Bolis.   

Abstract

Aim of the study was to evaluate the efficacy of tolterodine in relation to different urodynamic findings of detrusor overactivity (DO). Women with urodynamic diagnosis of DO were prospectively included into two groups: with involuntary detrusor contractions during the cystometric filling phase (group 1) or after provocative manoeuvres (group 2). Tolterodine 4 mg ER was prescribed to all women. Drug efficacy was assessed using a 3-point scale. Women were defined responders if they were improved/cured after 3 months of therapy, and non-responders if symptoms did not change. The outcome of therapy was compared between groups. A total of 111 women were included. The groups did not differ for demographic characteristics. After 12 weeks, we found a significant difference (P = 0.0008) between groups in terms of tolterodine efficacy with a better response rate in group 1. Our study shows that tolterodine efficacy may be related to different urodynamic findings of DO.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066482     DOI: 10.1007/s00192-007-0512-8

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  14 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies.

Authors:  Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 3.  The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis.

Authors:  Christopher Chapple; Vik Khullar; Zahava Gabriel; Julie Ann Dooley
Journal:  Eur Urol       Date:  2005-03-22       Impact factor: 20.096

4.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

5.  Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle.

Authors:  Y Igawa; Y Yamazaki; H Takeda; K Hayakawa; M Akahane; Y Ajisawa; T Yoneyama; O Nishizawa; K E Andersson
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 6.  Which anticholinergic drug for overactive bladder symptoms in adults.

Authors:  J Hay-Smith; P Herbison; G Ellis; A Morris
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

7.  Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: validation of three global patient ratings.

Authors:  Kathryn L Burgio; Patricia S Goode; Holly E Richter; Julie L Locher; David L Roth
Journal:  Neurourol Urodyn       Date:  2006       Impact factor: 2.696

Review 8.  Clinical pharmacology of potassium channel openers.

Authors:  K E Andersson
Journal:  Pharmacol Toxicol       Date:  1992-04

9.  Reproducibility and reliability of pressure flow parameters in women.

Authors:  G Alessandro Digesu; Anna Hutchings; Stefano Salvatore; Luigi Selvaggi; Vik Khullar
Journal:  BJOG       Date:  2003-08       Impact factor: 6.531

Review 10.  The vanilloid (capsaicin) receptor: receptor types and species differences.

Authors:  A Szallasi
Journal:  Gen Pharmacol       Date:  1994-03
View more
  3 in total

1.  Ultrasound measurement of bladder wall thickness in different forms of detrusor overactivity.

Authors:  Maurizio Serati; Stefano Salvatore; Elena Cattoni; Marco Soligo; Antonella Cromi; Fabio Ghezzi
Journal:  Int Urogynecol J       Date:  2010-06-10       Impact factor: 2.894

2.  Ultrasound thickness of bladder wall in continent and incontinent women and its correlation with cystometry.

Authors:  Edney Norio Otsuki; Edward Araujo Júnior; Emerson Oliveira; Marair Gracio Ferreira Sartori; Manoel João Batista Castelo Girão; Zsuzsanna Ilona Katalin Jármy-Di Bella
Journal:  ScientificWorldJournal       Date:  2014-11-04

Review 3.  Update on tolterodine extended-release for treatment of overactive bladder.

Authors:  Tola Omotosho; Chi Chiung Grace Chen
Journal:  Open Access J Urol       Date:  2010-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.